Elivity introduces NANOBOOST liquid supplement absorption technology across Asian markets
Health technology firm elivity introduced its proprietary NANOBOOST oral spray system across Asia to replace traditional tablet based nutritional supplement delivery methods for consumers
Singapore's longevity supplement brand elivity® has launched NANOBOOST, a patent-pending absorption technology, across Asia. Co-developed with a German biotech spin-off from Hamburg University, NANOBOOST is the first of its kind technology available in the region. The innovative delivery system, built on advanced liposomal science, encases active compounds in ultra-fine structures like liposomes, nanoemulsions, and hybrid systems.
These structures protect the compounds from degradation and enhance their absorption through the mucous membranes beneath the tongue, bypassing the digestive system entirely. This means active ingredients reach systemic circulation more efficiently, a critical factor for longevity-focused formulations. elivity®'s energize and melatonin sprays are the first products to incorporate this technology in Asia, addressing growing consumer concerns about supplement absorption.
The technology is part of elivity®'s strategy to expand its retail presence and product line across Asia, while also offering health indicators to consumers through its Body Scan Initiative.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
